MA26608A1 - Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. - Google Patents
Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.Info
- Publication number
- MA26608A1 MA26608A1 MA25465A MA25465A MA26608A1 MA 26608 A1 MA26608 A1 MA 26608A1 MA 25465 A MA25465 A MA 25465A MA 25465 A MA25465 A MA 25465A MA 26608 A1 MA26608 A1 MA 26608A1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- treatment
- pharmaceutical composition
- heart failure
- heart
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7493498P | 1998-02-17 | 1998-02-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26608A1 true MA26608A1 (fr) | 2004-12-20 |
Family
ID=22122537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25465A MA26608A1 (fr) | 1998-02-17 | 1999-02-16 | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. |
Country Status (28)
Country | Link |
---|---|
US (1) | US6043260A (fr) |
EP (1) | EP0951906A1 (fr) |
JP (1) | JPH11292766A (fr) |
KR (1) | KR19990072616A (fr) |
CN (1) | CN1231176A (fr) |
AP (1) | AP9901464A0 (fr) |
AR (1) | AR017723A1 (fr) |
AU (1) | AU1732999A (fr) |
BG (1) | BG103180A (fr) |
BR (1) | BR9900653A (fr) |
CA (1) | CA2262252C (fr) |
EA (1) | EA199900124A3 (fr) |
GT (1) | GT199900015A (fr) |
HR (1) | HRP990054A2 (fr) |
HU (1) | HUP9900386A3 (fr) |
ID (1) | ID23218A (fr) |
IL (1) | IL128531A0 (fr) |
IS (1) | IS4975A (fr) |
MA (1) | MA26608A1 (fr) |
NO (1) | NO990722L (fr) |
OA (1) | OA10976A (fr) |
PA (1) | PA8467401A1 (fr) |
PE (1) | PE20000266A1 (fr) |
PL (1) | PL331507A1 (fr) |
SG (1) | SG81261A1 (fr) |
TN (1) | TNSN99024A1 (fr) |
TR (1) | TR199900328A2 (fr) |
ZA (1) | ZA991220B (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403599B1 (en) | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
US7067664B1 (en) | 1995-06-06 | 2006-06-27 | Pfizer Inc. | Corticotropin releasing factor antagonists |
US6956047B1 (en) | 1995-06-06 | 2005-10-18 | Pfizer Inc. | Corticotropin releasing factor antagonists |
US6387894B1 (en) * | 1999-06-11 | 2002-05-14 | Pfizer Inc. | Use of CRF antagonists and renin-angiotensin system inhibitors |
EP1216037A2 (fr) | 1999-09-21 | 2002-06-26 | Emory University | Procedes et compositions pour le traitement de troubles lies aux plaquettes au moyen d'agents inhibiteurs de trajet de mpl |
KR20020063934A (ko) * | 2000-01-18 | 2002-08-07 | 화이자 프로덕츠 인코포레이티드 | 코르티코트로핀 방출 인자 길항제 |
US6737430B2 (en) | 2000-11-09 | 2004-05-18 | Pfizer, Inc. | Mutual prodrug of amlodipine and atorvastatin |
GB0027410D0 (en) * | 2000-11-09 | 2000-12-27 | Pfizer Ltd | Mutual prodrug of amlodipine and atorvastatin |
US6992087B2 (en) | 2001-11-21 | 2006-01-31 | Pfizer Inc | Substituted aryl 1,4-pyrazine derivatives |
BR0307584A (pt) | 2002-02-22 | 2005-02-01 | Upjohn Co | Pirimidinonas e pirimidinationas substituìdas |
AU2003220190A1 (en) * | 2002-03-13 | 2003-09-29 | Pharmacia & Upjohn Company Llc | Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators |
WO2003091225A1 (fr) * | 2002-04-26 | 2003-11-06 | Pharmacia & Upjohn Company | Derives pyraziniques substitues |
MXPA05002418A (es) * | 2002-09-12 | 2005-05-27 | Pharmacia & Upjohn Co Llc | Derivados de 1,4-pirazina sustituidos. |
AR041470A1 (es) * | 2002-10-17 | 2005-05-18 | Upjohn Co | Compuestos de pirrolo (1,2 - b) piridazina y sus usos |
AU2003278542A1 (en) * | 2002-11-21 | 2004-06-15 | Pharmacia & Upjohn Company Llc | Pyrazine compounds as crf modulators |
MXPA05011387A (es) * | 2003-04-23 | 2005-12-01 | Pharmacia & Upjohn Co Llc | Pirimidinonas y pirimidinotionas sustituidas. |
JP2006525309A (ja) * | 2003-05-07 | 2006-11-09 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | ピロロ(1,2−b)ピリダジン化合物、ならびにCRF−1受容体拮抗薬としてのその使用 |
EP1625115A1 (fr) * | 2003-05-09 | 2006-02-15 | Pharmacia & Upjohn Company LLC | Derives pyrimidiques substitues |
EP1625125A1 (fr) * | 2003-05-09 | 2006-02-15 | Pharmacia & Upjohn Company LLC | Composes utilises comme antagonistes du recepteur de type 1 de la corticoliberine (crf) |
CA2525195A1 (fr) * | 2003-05-09 | 2004-11-18 | Pharmacia & Upjohn Company Llc | Pyrazinones a titre d'antagonistes du recepteur de crf1 dans le traitement des troubles du systeme nerveux central |
WO2005089639A2 (fr) * | 2004-03-16 | 2005-09-29 | Talarico M D Matthew T | Procede de deregulation vasculaire |
US20060211710A1 (en) * | 2005-03-17 | 2006-09-21 | Pfizer Inc | Substituted aryl 1,4-pyrazine derivatives |
US8338441B2 (en) * | 2009-05-15 | 2012-12-25 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW530047B (en) * | 1994-06-08 | 2003-05-01 | Pfizer | Corticotropin releasing factor antagonists |
US6403599B1 (en) * | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
EP0795327A1 (fr) * | 1996-03-13 | 1997-09-17 | Pfizer Inc. | Utilisation de l'amlodipine pour le traitement et la prophylaxie de l'insuffisance cardiaque congestive d'origine non-ischémique |
-
1999
- 1999-01-18 PA PA19998467401A patent/PA8467401A1/es unknown
- 1999-02-02 GT GT199900015A patent/GT199900015A/es unknown
- 1999-02-10 US US09/248,073 patent/US6043260A/en not_active Expired - Fee Related
- 1999-02-10 SG SG9900526A patent/SG81261A1/en unknown
- 1999-02-11 IS IS4975A patent/IS4975A/is unknown
- 1999-02-11 AP APAP/P/1999/001464A patent/AP9901464A0/en unknown
- 1999-02-11 EP EP99301006A patent/EP0951906A1/fr not_active Withdrawn
- 1999-02-11 CN CN99102122A patent/CN1231176A/zh active Pending
- 1999-02-12 BR BR9900653-7A patent/BR9900653A/pt not_active Application Discontinuation
- 1999-02-12 PE PE1999000127A patent/PE20000266A1/es not_active Application Discontinuation
- 1999-02-12 KR KR1019990004934A patent/KR19990072616A/ko not_active Application Discontinuation
- 1999-02-15 CA CA002262252A patent/CA2262252C/fr not_active Expired - Fee Related
- 1999-02-15 ID IDP990113D patent/ID23218A/id unknown
- 1999-02-15 IL IL12853199A patent/IL128531A0/xx unknown
- 1999-02-16 AU AU17329/99A patent/AU1732999A/en not_active Abandoned
- 1999-02-16 AR ARP990100619A patent/AR017723A1/es unknown
- 1999-02-16 MA MA25465A patent/MA26608A1/fr unknown
- 1999-02-16 NO NO990722A patent/NO990722L/no unknown
- 1999-02-16 TN TNTNSN99024A patent/TNSN99024A1/fr unknown
- 1999-02-16 JP JP11037464A patent/JPH11292766A/ja active Pending
- 1999-02-16 TR TR1999/00328A patent/TR199900328A2/xx unknown
- 1999-02-16 BG BG103180A patent/BG103180A/bg unknown
- 1999-02-16 HU HU9900386A patent/HUP9900386A3/hu unknown
- 1999-02-16 ZA ZA9901220A patent/ZA991220B/xx unknown
- 1999-02-16 OA OA9900034A patent/OA10976A/en unknown
- 1999-02-16 EA EA199900124A patent/EA199900124A3/ru unknown
- 1999-02-17 HR HR60/074,934A patent/HRP990054A2/hr not_active Application Discontinuation
- 1999-02-17 PL PL99331507A patent/PL331507A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GT199900015A (es) | 2000-07-26 |
AR017723A1 (es) | 2001-09-12 |
CA2262252A1 (fr) | 1999-08-17 |
KR19990072616A (ko) | 1999-09-27 |
TR199900328A2 (xx) | 1999-10-21 |
IL128531A0 (en) | 2000-01-31 |
NO990722L (no) | 1999-08-18 |
CN1231176A (zh) | 1999-10-13 |
IS4975A (is) | 1999-08-18 |
HUP9900386A2 (hu) | 1999-11-29 |
ZA991220B (en) | 2000-08-16 |
NO990722D0 (no) | 1999-02-16 |
AP9901464A0 (en) | 1999-03-31 |
EA199900124A3 (ru) | 1999-12-29 |
BR9900653A (pt) | 2000-10-17 |
PL331507A1 (en) | 1999-08-30 |
US6043260A (en) | 2000-03-28 |
HUP9900386A3 (en) | 1999-12-28 |
HRP990054A2 (en) | 2000-02-29 |
ID23218A (id) | 2000-03-30 |
JPH11292766A (ja) | 1999-10-26 |
AU1732999A (en) | 1999-09-02 |
BG103180A (bg) | 1999-09-30 |
SG81261A1 (en) | 2001-06-19 |
TNSN99024A1 (fr) | 2005-11-10 |
CA2262252C (fr) | 2006-01-10 |
EA199900124A2 (ru) | 1999-08-26 |
OA10976A (en) | 2001-11-05 |
EP0951906A1 (fr) | 1999-10-27 |
PE20000266A1 (es) | 2000-04-07 |
PA8467401A1 (es) | 2000-09-29 |
HU9900386D0 (en) | 1999-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26608A1 (fr) | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. | |
MA21682A1 (fr) | Procede de preparation d'agents therapeutiques derives de la quainclidine. | |
MA26471A1 (fr) | Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA22481A1 (fr) | Procede de preparation d'acides imidazolyl - alcenoiques . | |
MA23091A1 (fr) | Procede de preparation d'agents antiparasitaires . | |
MA22626A1 (fr) | Procede de preparation d'acides imidazolyl-alcenoiques . | |
MA26536A1 (fr) | Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation. | |
FR2734483B1 (fr) | Forme d'administration pharmaceutique comprenant de l'oxybutynine | |
MA23143A1 (fr) | Procede pour la preparation de compositions vaccinantes . | |
IT1230756B (it) | Metodo per la preparazione di polibutadiene a lavorabilita' migliorata. | |
MA24581A1 (fr) | Procede de preparation de composes utiles pour le traitement de la resistance a l'insuline . | |
DZ3014A1 (fr) | Médicaments pour le traitement de l'hypertension. | |
MA22443A1 (fr) | Procede de preparation d'une composition pharmaceutique . | |
MA21922A1 (fr) | Procede de purification d'acides aminomethylene-phosphoniques . | |
FR2697248B1 (fr) | Procede de preparation du dichlorure d'acide l-5-(2-acetoxy-propionylamino)-2,4,6-triiodo-isophtalique. | |
DE69533876D1 (de) | Zusammensetzung für die gentherapeutische Behandlung von Koronar-Arterienerkrankungen. | |
PH31643A (en) | 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease. | |
MA23663A1 (fr) | Procede de preparation de formulations pharmaceutiques | |
DZ2619A1 (fr) | Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoïques substitués. | |
FR2715656B1 (fr) | Procédé de préparation d'anhydride citraconique. | |
DZ2564A1 (fr) | Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés. | |
ATE218856T1 (de) | Aminotetralinderivat zur behandlung von herzkreislauferkrankung | |
FR2733227B1 (fr) | Procede pour la preparation de 1,1-difluoroethane | |
DZ2423A1 (fr) | Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoiques substitués. | |
FR2739373B1 (fr) | Procede de preparation de catalyseurs d'ammoxydation |